Protonitazene: Revision history


For any version listed below, click on its date to view it. For more help, see Help:Page history and Help:Edit summary. (cur) = difference from current version, (prev) = difference from preceding version, m = minor edit, → = section edit, ← = automatic edit summary

10 March 2024

8 February 2024

8 December 2023

22 November 2023

28 August 2023

26 August 2023

26 July 2023

25 July 2023

9 July 2023

12 June 2023

17 April 2023

15 April 2023

15 March 2023

6 March 2023

26 January 2023

25 December 2022

8 December 2022

  • curprev 19:5519:55, 8 December 2022Boghog talk contribs 3,365 bytes +501 templated cites undo
  • curprev 08:4608:46, 8 December 2022Meodipt talk contribs 2,864 bytes +5 No edit summary undo
  • curprev 08:4508:45, 8 December 2022Meodipt talk contribs 2,859 bytes +2,859 Created page with '{{drugbox | drug_name = Protonitazene | image = Protonitazene_structure.png | legal_UK = PSA | legal_US = Schedule I | legal_DE = NpSG | C = 23 | H = 30 | N = 4 | O = 3 | IUPAC_name = 2-[(4-Propoxyphenyl)methyl]-5-nitro-1-(2-pyrrolidin-1-ylethyl)benzimidazole | CAS_number = 95958-84-2 | ChemSpiderID = | PubChem = 156589001 | UNII = 4A6RZQ7M2V | smiles = CCCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-] | StdInChI=1S/C23H30N4O3/c1...'